Colgate-Palmolive Company: Q2 2001 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Company for the period ended June 30, 2001. The company operates globally in Oral, Personal, and Household Care, as well as Pet Nutrition. As of July 31, 2001, there were 554,988,615 shares of common stock outstanding.
Key Financial Metrics
| Metric (in millions) | Q2 2001 | Q2 2000 | 6 Months 2001 | 6 Months 2000 |
|---|---|---|---|---|
| Net Sales | $2,329.6 | $2,336.7 | $4,622.2 | $4,578.5 |
| Gross Profit | $1,278.6 | $1,270.9 | $2,538.4 | $2,492.1 |
| Gross Margin | 54.9% | 54.4% | 54.9% | 54.4% |
| Net Income | $287.2 | $261.9 | $555.1 | $501.8 |
| Diluted EPS | $0.47 | $0.42 | $0.91 | $0.80 |
| Operating Cash Flow (6mo) | $621.9 (2001) vs $657.2 (2000) | |||
| Cash & Equivalents | $251.1 (June 30, 2001) | |||
| Total Debt (Current + Long-term) | $3,398.6 (June 30, 2001) |
Material Changes vs. Prior Period
- Revenue: Q2 2001 sales were flat year-over-year (-0.3%), driven by a 5% unit volume gain offset by unfavorable foreign currency fluctuations. Excluding currency, sales would have risen 5%.
- Profitability: Net income increased 10% in Q2 and 11% for the first half of 2001. Gross margins improved to 54.9% due to manufacturing cost reductions and global sourcing.
- Expenses: Selling, general, and administrative (SG&A) expenses as a percentage of sales decreased to 34.7% in Q2 2001 from 35.6% in 2000, aided by advertising efficiencies and translation effects.
- Segment Performance:
- North America: Sales up 3% (Q2) and 4% (6mo) on volume growth.
- Latin America: Sales down 1% (Q2) but up 1% (6mo) excluding divestments; volume up 4%.
- Europe: Sales down 1% (Q2) due to the weakened Euro, despite 6% volume growth.
- Asia/Africa: Sales down 2% (Q2) due to currency, masking 7% volume growth.
- Pet Nutrition: Sales up 5% (Q2) and 4% (6mo) on volume gains.
Guidance, Outlook, and Risks
- Outlook: Management estimates the full-year effective income tax rate to be 32.7%, slightly higher than the 2000 rate of 32.1%.
- Accounting Changes: The company will adopt FASB Statements No. 141 and 142 effective January 1, 2002. These changes will stop the amortization of goodwill and indefinite-life intangible assets, requiring annual impairment testing instead. The impact is currently being evaluated.
- Liquidity: Operating cash flow was $621.9 million for the first half of 2001. This figure includes a non-recurring tax payment related to the prior year's sale of the Viva detergent brand in Mexico. Excluding this, cash generation matched the record levels of the prior year.
- Capital Allocation: The company spent $706.0 million on share repurchases in the first half of 2001 and paid $187.1 million in dividends.
Investor Verification Checklist
- Currency Impact: Verify the extent to which reported sales declines in Europe and Asia/Africa are masked by strong underlying volume growth.
- Debt Structure: Note that $795.9 million of commercial paper is classified as long-term debt based on refinancing intent; verify the company's ability to refinance these obligations.
- Accounting Transition: Monitor the impact of the upcoming adoption of SFAS 142 on future earnings, specifically regarding the cessation of goodwill amortization.
- One-Time Items: Adjust operating cash flow analysis to exclude the non-recurring tax payment related to the Viva brand sale to assess true operational cash generation.
- Share Repurchases: Review the $706 million in stock buybacks against the company's liquidity position and future capital expenditure needs.